TNFR2 Agonism as a Sex-Specific Therapy for Novel Osteoarthritis-Induced Cardiac Dysfunction

Prasoon P, Tammen K, Russo R, Meyyappan A, Dalvi M, Fischer R, Eschborn M, Arnab S, Brabbee L, Schneider L, Nguyen K, Mendelowitz D, Kay MW, Bethea JR.

Open source

DOI
10.64898/2026.07.06.736778
Published
2026-07-10
Container
Not recorded
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.07.06.736778,
  title = {TNFR2 Agonism as a Sex-Specific Therapy for Novel Osteoarthritis-Induced Cardiac Dysfunction},
  author = {Prasoon P and  Tammen K and  Russo R and  Meyyappan A and  Dalvi M and  Fischer R and  Eschborn M and  Arnab S and  Brabbee L and  Schneider L and  Nguyen K and  Mendelowitz D and  Kay MW and  Bethea JR.},
  year = {2026},
  doi = {10.64898/2026.07.06.736778},
  url = {https://doi.org/10.64898/2026.07.06.736778}
}

RIS

TY  - JOUR
TI  - TNFR2 Agonism as a Sex-Specific Therapy for Novel Osteoarthritis-Induced Cardiac Dysfunction
AU  - Prasoon P
AU  -  Tammen K
AU  -  Russo R
AU  -  Meyyappan A
AU  -  Dalvi M
AU  -  Fischer R
AU  -  Eschborn M
AU  -  Arnab S
AU  -  Brabbee L
AU  -  Schneider L
AU  -  Nguyen K
AU  -  Mendelowitz D
AU  -  Kay MW
AU  -  Bethea JR.
PY  - 2026
DO  - 10.64898/2026.07.06.736778
UR  - https://doi.org/10.64898/2026.07.06.736778
ER  - 

APA

P, P., K, T., R, R., A, M., M, D., R, F., M, E., S, A., L, B., L, S., K, N., D, M., MW, K., & JR., B. (2026). TNFR2 Agonism as a Sex-Specific Therapy for Novel Osteoarthritis-Induced Cardiac Dysfunction. https://doi.org/10.64898/2026.07.06.736778

Source records